Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Long-Term Investments (2023 - 2025)

Historic Long-Term Investments for Maxcyte (MXCT) over the last 3 years, with Q3 2025 value amounting to $52.3 million.

  • Maxcyte's Long-Term Investments rose 2214.41% to $52.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.3 million, marking a year-over-year increase of 2214.41%. This contributed to the annual value of $35.8 million for FY2024, which is 1666.82% down from last year.
  • Latest data reveals that Maxcyte reported Long-Term Investments of $52.3 million as of Q3 2025, which was up 2214.41% from $38.6 million recorded in Q2 2025.
  • Maxcyte's Long-Term Investments' 5-year high stood at $52.3 million during Q3 2025, with a 5-year trough of $18.4 million in Q3 2023.
  • Over the past 3 years, Maxcyte's median Long-Term Investments value was $42.5 million (recorded in 2024), while the average stood at $39.4 million.
  • Per our database at Business Quant, Maxcyte's Long-Term Investments soared by 13223.02% in 2024 and then plummeted by 1911.57% in 2025.
  • Quarter analysis of 3 years shows Maxcyte's Long-Term Investments stood at $42.9 million in 2023, then decreased by 16.67% to $35.8 million in 2024, then surged by 46.09% to $52.3 million in 2025.
  • Its Long-Term Investments was $52.3 million in Q3 2025, compared to $38.6 million in Q2 2025 and $36.4 million in Q1 2025.